John A. Morgan

BACKGROUND

Passionate about the confluence of science, business, and law, John has supported through his patent practice innovations for cancer and a variety of other diseases (infectious, neurodegenerative, lysosomal storage, autoimmune, genetic), as well as cellular agriculture. His passion for science stems from his time as a researcher at the Fred Hutchinson Cancer Center in Seattle, where he studied cell signaling and tissue patterning in the developing vertebrate brain, as well as cell growth genes in an invertebrate model. John appreciates supporting his clients’ efforts to improve human health and sustainable practices. He also has experience in the chemical and mechanical arts.

John received his J.D. summa cum laude from Seattle University School of Law (2014) and his B.S. from the University of Puget Sound.

EXPERIENCE

John advises biotechnology companies, investors, and research institutions on intellectual property matters for a variety of complex technologies, including therapeutic antibodies and fusion proteins, cell and gene therapies, vaccines, antisense therapies, engineered microorganisms, biologics manufacturing, and diagnostics.

In his practice, John aligns intellectual property strategies with his clients’ business and technology objectives. John’s natural curiosity, attention to detail, and creativity are applied to patent counseling, prosecution, landscape and freedom-to-operate analysis, and due diligence. His clients include companies (from early stages through clinical trials and approval), investors, would-be-collaborators, and investment targets, licensors and licensees.

AFFILIATIONS

John is admitted to the Washington State Bar and is registered to practice before the United States Patent and Trademark Office and the United States District Court for the Western District of Washington. He is a member of the Washington Patent Law Association (WSPLA) and Life Science Washington.